Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
American Pharmacy|July 1, 1989
Cancer detection and the community pharmacistB L Lum, D S McWaters, M A MergenerDrug Intelligence & Clinical Pharmacy|February 1, 1987
Evaluation of three manual drug information retrieval systems for investigational antineoplastic drugsA Al Hefzi, P N Catania, M A Mergener, et al.Clinical Pharmacology and Therapeutics|March 15, 2016
Should Therapeutic Drug Monitoring for Monoclonal Antibodies Remain the Exception or Become the Norm?M Stroh, B L LumAmerican Journal of Hospital Pharmacy|February 1, 1990
Therapeutic outcome of elderly and nonelderly patients receiving home intravenous antimicrobial therapyT Chattopadhyay, P N Catania, M A MergenerCancer Treatment Reviews|December 1, 1985
Therapeutic approaches including interferon to carcinoma in situ of the bladderB L Lum, F M TortiJournal of the National Cancer Institute|May 15, 1991
Adjuvant intravesicular pharmacotherapy for superficial bladder cancerB L Lum, F M TortiSeminars in Oncology|September 1, 1986
Superficial carcinoma of the bladder: natural history and the role of interferonsF M Torti, B L LumHematology/Oncology Clinics of North America|April 1, 1995
MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitorsB L Lum, M P GoslandJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1984
The biology and treatment of superficial bladder cancerF M Torti, B L LumCancer|February 1, 1987
Superficial bladder cancer. Risk of recurrence and potential role for interferon therapyF M Torti, B L LumPageof 6